West Paces Advisors’s Organon & Co OGN Stock Holding History

West Paces Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$30	–	444
2025 Q1	$30	Hold	2	–	–	﹤0.01%	561
2024 Q4	$30	Hold	2	–	–	﹤0.01%	555
2024 Q3	$38	Hold	2	–	–	﹤0.01%	544
2024 Q2	$41	Hold	2	–	–	﹤0.01%	563
2024 Q1	$38	Hold	2	–	–	﹤0.01%	579
2023 Q4	$29	Sell	2 -198	-99%	-$2.69K	﹤0.01%	606
2023 Q3	$3.47K	Buy	200 +151	+308%	+$3.15K	﹤0.01%	407
2023 Q2	$1.02K	Buy	49 +39	+390%	+$848	﹤0.01%	493
2023 Q1	$235	Hold	10	–	–	﹤0.01%	546
2022 Q4	$279	Hold	10	–	–	﹤0.01%	521
2022 Q3	$234	Sell	10 -14	-58%	-$423	﹤0.01%	513
2022 Q2	$810	Sell	24 -281	-92%	-$9.84K	﹤0.01%	532
2022 Q1	$10.7K	Sell	305 -90	-23%	-$3.08K	﹤0.01%	367
2021 Q4	$12K	Buy	395 +100	+34%	+$3.26K	﹤0.01%	361
2021 Q3	$9.67K	Hold	295	–	–	﹤0.01%	362
2021 Q2	$8.93K	Buy	+295	New	+$9.71K	﹤0.01%	371

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

West Paces Advisors's OGN Position: Q2 2025 in Review

West Paces Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 2 shares — an estimated $30 sold.

West Paces Advisors first reported a position in OGN in Q2 2021 and held it in 16 quarters. The position peaked at $12K in Q4 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

West Paces Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
West Paces Advisors sold 2 Organon & Co shares in Q2 2025, an estimated $30.
West Paces Advisors first reported a position in Organon & Co in Q2 2021 and held it in 16 quarters.
West Paces Advisors's Organon & Co position peaked at $12K in Q4 2021.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.